Clinical trial
First-Line Capecitabine and Cetuximab for Metastatic Colorectal Ca in Elderly…
NCT00251186 · University of Medicine and Dentistry of New Jersey, Other · Terminated
Key facts
| NCT number | NCT00251186 |
|---|---|
| Title | First-Line Capecitabine and Cetuximab for Metastatic Colorectal Ca in Elderly Patients |
| Official title | Phase II Study of First-Line Capecitabine and Cetuximab for Treatment of Metastatic Colorectal Cancer in Elderly Patients and/or Those With Multiple Comorbidities Unable to Receive Chemotherapy Doublets |
| Lead sponsor | University of Medicine and Dentistry of New Jersey, Other |
| Collaborators | Rutgers Cancer Institute of New Jersey Bristol-Myers Squibb Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | Capecitabine and Cetuximab |
| Enrollment | 18 |
| Start date | Apr 1, 2006 |
| Primary completion | Apr 1, 2006 |
| Completion | Apr 1, 2006 |
| First posted | Nov 9, 2005 |
| Last update posted | Jan 26, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: